GlassScriptPhysician profile
Gregory P Forlenza
NPI 1770788085
$199,783.89
in general payments reported to CMS, 2019-2025
7 companies · $66K in 2025
The $66K reported for 2025 was more than what 98% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $11K · 2021: $31K · 2022: $18K · 2023: $28K · 2024: $34K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $31K · Consulting Fee: $23K · Travel and Lodging: $4,398 · Food and Beverage: $2,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,811.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $31,059.00 |
| Consulting Fee | $23,452.50 |
| Travel and Lodging | $4,398.42 |
| Food and Beverage | $2,178.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $99,459.07 | 2019-2025 | Omnipod, Omnipod |
| Medtronic, INC. | $60,240.78 | 2021-2025 | Minimed 780g, Minimed 770g |
| Dexcom, INC. | $15,019.10 | 2019-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Eli Lilly and Company | $11,025.00 | 2021-2022 | |
| Medtronic Minimed, INC. | $10,578.63 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $3,092.67 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $368.64 | 2024 | Freestyle Libre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Forlenza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.